SCHEMBL6295463

SCHEMBL6295463

O=c1[nH]c(=O)n(CCCS)c2ccccc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 6/20 0.50
DAO P14920 1/20 0.49
HTR1A P08908 1/20 0.48
DRD2 P14416 1/20 0.48
HTR2A P28223 1/20 0.48
ALDH1A1 P00352 2/20 0.47
HPGD P15428 2/20 0.47
LMNA P02545 2/20 0.47
MAPT P10636 1/20 0.47
TSHR P16473 1/20 0.47
MAPK1 P28482 1/20 0.47
HTT P42858 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
POLB P06746 1/20 0.43
PGR P06401 1/20 0.42
RORA P35398 1/20 0.42
RORC P51449 1/20 0.42
RORB Q92753 1/20 0.42
MPO P05164 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6294349 0.90 PARP1 (0.52) PARP1DAOHTR1ADRD2HTR2A
SCHEMBL6028786 0.84 PGR (0.60) PARP1DAOHTR1ADRD2HTR2A
SCHEMBL446902 0.84 PARP1 (0.50) PARP1DAOHTR1ADRD2HTR2A
SCHEMBL29528989 0.84 PGR (0.60) PARP1DAOHTR1ADRD2HTR2A
SCHEMBL10827376 0.84 PARP1 (0.50) PARP1DAOHTR1ADRD2HTR2A
SCHEMBL11009779 0.84 ALDH1A1 (0.60) PARP1DAOHTR1ADRD2HTR2A
SCHEMBL7650175 0.83 PARP1 (0.50) PARP1DAOHTR1ADRD2HTR2A
SCHEMBL7305582 0.83 HTR1A (0.50) PARP1DAOHTR1ADRD2HTR2A
SCHEMBL7298333 0.83 ALDH1A1 (0.55) PARP1DAOHTR1ADRD2HTR2A
SCHEMBL7750879 0.83 PGR (0.55) PARP1DAOHTR1ADRD2HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6872727-B1 Polycyclic pyrimidine -2,4(1H,3H)-diones with functionalized alkyl residues at the 1- and/or 3-position(s); methods for their synthesis and pharmaceutical preparation PRIVATES INSTITUT FUR BIOMEDIZINISCHE FORSCHUNG UND BERATUNG (DE) 2005-03-29 US disclosed
EP-1150964-B1 POLYCYCLIC PYRIMIDINE-2,4(1H, 3H)-DIONE WITH FUNCTIONALIZED ALKYL RADICALS IN 1- AND/OR 3-POSITION, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS IBFB GMBH PRIVATES INST FUER B (DE) 2003-10-29 EP disclosed
EP-1150964-A2 POLYCYCLIC PYRIMIDINE-2,4(1H, 3H)-DIONE WITH FUNCTIONALIZED ALKYL RADICALS IN 1- AND/OR 3-POSITION, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS IBFB GmbH Privates Institut für biomedizinische Forschung und Beratung (DE) 2001-11-07 EP disclosed
WO-2001014344-A2 POLYCYCLIC PYRIMIDINE-2,4(1H, 3H)-DIONE WITH FUNCTIONALIZED ALKYL RADICALS IN 1- AND/OR 3-POSITION, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS IBFB GMBH PRIVATES INSTITUT FÜR BIOMEDIZINISCHE FORSCHUNG UND BERATUNG (DE) 2001-03-01 WO disclosed